9
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      The Effect of Positive End-Expiratory Pressure on the Coronary Blood Flow

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Positive end-expiratory pressure (PEEP) is used liberally whenever a ventilated patient shows signs of increased pulmonary venous shunting. Clinicians using PEEP to improve blood oxygenation may face the cardiovascular side effects which limit utilization of the desired respiratory effects of PEEP. We measured the pressure flow characteristics of the cardiovascular system and the coronary arterial system as a function of PEEP, using closed-chest surgically instrumented dogs, in order to assess its effects on myocardial blood flow with respect to the left ventricular energy demands. The aortic left ventricular blood pressure as well as the aortic blood flow decreased with increasing PEEP values. The coronary blood flow decreased by 5% for PEEP values of 4 cm H<sub>2</sub>O, and by 25% for 14 cm H<sub>2</sub>O of PEEP. PEEP values under 10 cm H<sub>2</sub>O reduced the left ventricular end-diastolic pressure (LVEDP), while higher PEEP values caused an increase in LVEDP. The relation between the alterations of coronary and aortic blood flows changed with PEEP values. Low PEEP values (less than 10 cm H<sub>2</sub>O) had a tendency for higher relative reduction of aortic blood flow, whereas higher PEEP values (higher than 10 cm H<sub>2</sub>O) reduced the coronary blood flow more than the reduction occurring in the aortic blood flow. Our results suggest that low PEEP values may have beneficial effects on the relation between aortic blood flow and coronary blood flow, therefore low PEEP application may minimize hypoxic myocardial alterations. Further studies that will measure left ventricular workload or another metabolic index for estimating myocardial perfusion relative to its metabolic demand are essential before clinical conclusions can be drawn from our results.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          1989
          1989
          11 November 2008
          : 76
          : 3
          : 193-200
          Affiliations
          aCardiovascular Research Group, Departments of Physiology and Biophysics, Rappaport Family Institute for Research in the Medical Sciences, bDepartment of thoracicSurgery, Carmel Hospital, Kupat Holim, and cDepartment of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa, Israel
          Article
          174490 Cardiology 1989;76:193–200
          10.1159/000174490
          2673512
          798aaa00-92f9-46d5-929a-cc643b242f0e
          © 1989 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 19 February 1988
          : 20 February 1989
          Page count
          Pages: 8
          Categories
          Original Paper

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Aortic blood flow,Positive end-expiratory pressure,Coronary blood flow,Electromagnetic flow measurement

          Comments

          Comment on this article